MR [Mindray Medical International] SC 13G/A: (Original Filing)

[1. Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only). Baillie Gifford & Co (Scottish partnership) _______________________________________________________________________ 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a).................................................................... (b).................................................................... _______________________________________________________________________ 3. SEC Use Only _______________________________________________________________________ 4. Citizenship or Place of Organization SCOTLAND UK _______________________________________________________________________ Number of 5. Sole Voting Power 0 Shares Bene ______________________________________________________]

MR [Mindray Medical International] SC 13G/A: 1. Names of Reporting Persons. I.R.S. Identification Nos.

[1. Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only). Baillie Gifford & Co (Scottish partnership) _______________________________________________________________________ 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a).................................................................... (b).................................................................... _______________________________________________________________________ 3. SEC Use Only _______________________________________________________________________ 4. Citizenship or Place of Organization SCOTLAND UK _______________________________________________________________________ Number of 5. Sole Voting Power 0 Shares Bene ______________________________________________________]

MR [Mindray Medical International] 25-NSE: (Original Filing)

[.FormData {color: blue; background-color: white; font-size: small; font-family: Times, serif;} .FormDataC {color: blue; background-color: white; font-size: small; font-family: Times, serif; text-align: center;} .FormDataR {color: blue; background-color: white; font-size: small; font-family: Times, serif; text-align: right;} .SmallFormData {color: blue; background-color: white; font-size: x-small; font-family: Times, serif;} .FootnoteData {color: green; background-color: white; font-size: x-small; font-family: Times, serif;} .FormNumText {font-size: small; font-weight: bold; font-family:] []

MR [Mindray Medical International] 25-NSE: .FormData {color: blue; background-color: white; font-size: small; font-family:

[.FormData {color: blue; background-color: white; font-size: small; font-family: Times, serif;} .FormDataC {color: blue; background-color: white; font-size: small; font-family: Times, serif; text-align: center;} .FormDataR {color: blue; background-color: white; font-size: small; font-family: Times, serif; text-align: right;} .SmallFormData {color: blue; background-color: white; font-size: x-small; font-family: Times, serif;} .FootnoteData {color: green; background-color: white; font-size: x-small; font-family: Times, serif;} .FormNumText {font-size: small; font-weight: bold; font-family:] []

MR [Mindray Medical International] 6-K: Mindray Announces Completion of Going Private Transaction Under

[Mindray Announces Completion of Going Private Transaction Under the terms of the Merger Agreement, which was approved by the Company’s shareholders at an extraordinary general meeting held on February 26, 2016, each of the Company’s ordinary shares, consisting of Class A ordinary shares and Class B ordinary shares, par value HK$0.001 per share (each, a “Share”), issued and outstanding immediately] []

Skip to toolbar